Inicio > Cardiología > El valor de los bloqueadores del receptor de la angiotensina en las complicaciones renales y cardiacas > Página 4

El valor de los bloqueadores del receptor de la angiotensina en las complicaciones renales y cardiacas

23. Yamashita T, Inoue H, Okumura K. Randomized trial of angiotensin II-receptor blocker versus dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II Study). Europace 2011;13:473–9.

24. Mauer M, Zinman B, Gardiner R. Renal and retinal effects of enalapril and losartan in Type 1 diabetes. N Engl J Med 2009;361:40–51.

25. Flávio Danni Fuchs. The Role of Angiotensin Receptor Blockers in the Prevention of Cardiovascular and Renal Disease. Time for Reassessment?. Evid Based Med. 2013;18(2):44-47.

26. Yusuf S, Teo KK, Pogue J. ONTARGET Investigators, Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008;358: 1547–59.

27. Mann JF, Schmieder RE, Dyal L. TRANSCEND Investigators. Effect of telmisartan on renal outcomes: a randomized trial. Ann Intern Med 2009;151:1–10.